Validation of next‑generation sequencing‑derived circulating mRNA variants as potential diagnostic tools in hepatocellular carcinoma and cholangiocarcinoma.

Zezulinski D, Hoteit MA, Kaplan DE, Zhan T, Doria C, Block TM, Sayeed A

Open source

DOI
10.3892/or.2026.9196
Published
2026 Nov
Container
Oncology reports
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3892/or.2026.9196,
  title = {Validation of next‑generation sequencing‑derived circulating mRNA variants as potential diagnostic tools in hepatocellular carcinoma and cholangiocarcinoma.},
  author = {Zezulinski D and Hoteit MA and Kaplan DE and Zhan T and Doria C and Block TM and Sayeed A},
  year = {2026},
  journal = {Oncology reports},
  doi = {10.3892/or.2026.9196},
  url = {https://doi.org/10.3892/or.2026.9196}
}

RIS

TY  - JOUR
TI  - Validation of next‑generation sequencing‑derived circulating mRNA variants as potential diagnostic tools in hepatocellular carcinoma and cholangiocarcinoma.
AU  - Zezulinski D
AU  - Hoteit MA
AU  - Kaplan DE
AU  - Zhan T
AU  - Doria C
AU  - Block TM
AU  - Sayeed A
PY  - 2026
JO  - Oncology reports
DO  - 10.3892/or.2026.9196
UR  - https://doi.org/10.3892/or.2026.9196
ER  - 

APA

D, Z., MA, H., DE, K., T, Z., C, D., TM, B., & A, S. (2026). Validation of next‑generation sequencing‑derived circulating mRNA variants as potential diagnostic tools in hepatocellular carcinoma and cholangiocarcinoma.. Oncology reports. https://doi.org/10.3892/or.2026.9196

Source records